MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demazumder, D.
Right arrow Articles by Dilger, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demazumder, D.
Right arrow Articles by Dilger, J. P.

Vol. 60, Issue 4, 797-807, October 2001

The Kinetics of Competitive Antagonism by Cisatracurium of Embryonic and Adult Nicotinic Acetylcholine Receptors

Deeptankar Demazumder and James P. Dilger

Department of Physiology and Biophysics, State University of New York (SUNY) at Stony Brook, and Department of Anesthesiology, Health Sciences Center at SUNY Stony Brook, Stony Brook, New York

Competitive antagonists to nicotinic acetylcholine receptors are clinically used as muscle relaxants. Previously, we reported the kinetics of inhibition (in the absence of acetylcholine) by (+)-tubocurarine and pancuronium on embryonic receptors. Here, we examine cisatracurium, a commonly used muscle relaxant. Outside-out patches were equilibrated with cisatracurium before application of 300 µM acetylcholine. cisatracurium inhibited the initial peak current, but the decay of these currents displayed a pronounced biphasic behavior. The IC50 value was 54 ± 2 nM and 115 ± 4 nM for adult and embryonic receptors, respectively. We designed a rapid perfusion system to apply or remove cisatracurium for various times before application of acetylcholine. We determined the association (embryonic, 3.4 ± 0.4 × 108 M-1 s-1; adult, 1.8 ± 0.3 × 108 M-1 s-1) and dissociation (embryonic, 34 ± 6/s; adult: 13 ± 5/s) rates for cisatracurium. Association was 2.9- and 1.3-fold greater than that of (+)-tubocurarine and pancuronium, respectively. Dissociation was 6- and 16-fold higher than (+)-tubocurarine and pancuronium, respectively. These measurements correspond to dissociation of cisatracurium from receptors in the absence of acetylcholine. Physiologically, acetylcholine interacts with receptors equilibrated with antagonist. We developed a mathematical technique that removes the effect of desensitization and determined dissociation (embryonic, 52 ± 9/s; adult, 33 ± 5/s) in the presence of acetylcholine. These data suggest that presence of acetylcholine on one binding site of the receptor increases the dissociation rate of antagonist from the other binding site. We incorporated all of these rates into a computer simulation of a comprehensive 11-state Markov model. There was excellent agreement (without curve fitting) between simulated and experimental currents.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Liu and J. P. Dilger
Site Selectivity of Competitive Antagonists for the Mouse Adult Muscle Nicotinic Acetylcholine Receptor
Mol. Pharmacol., January 1, 2009; 75(1): 166 - 173.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Liu and J. P. Dilger
Synergy Between Pairs of Competitive Antagonists at Adult Human Muscle Acetylcholine Receptors
Anesth. Analg., August 1, 2008; 107(2): 525 - 533.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. Demazumder and J. P. Dilger
The kinetics of competitive antagonism of nicotinic acetylcholine receptors at physiological temperature
J. Physiol., February 15, 2008; 586(4): 951 - 963.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. K. Ford, M. Matchett, J. E. Krause, and W. Yu
The P2X3 Antagonist P1, P5-Di[inosine-5'] Pentaphosphate Binds to the Desensitized State of the Receptor in Rat Dorsal Root Ganglion Neurons
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 405 - 413.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. Wenningmann and J. P. Dilger
The Kinetics of Inhibition of Nicotinic Acetylcholine Receptors by (+)-Tubocurarine and Pancuronium
Mol. Pharmacol., October 1, 2001; 60(4): 790 - 796.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics